Early onset fetal growth restriction

Fetal growth restriction (FGR) diagnosed before 32 weeks is identified by fetal smallness associated with Doppler abnormalities and is associated with significant perinatal morbidity and mortality and maternal complications. Recent studies have provided new insights into pathophysiology, management...

Descripción completa

Detalles Bibliográficos
Autores principales: Dall’Asta, Andrea, Brunelli, Valentina, Prefumo, Federico, Frusca, Tiziana, Lees, Christoph C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241928/
https://www.ncbi.nlm.nih.gov/pubmed/28116113
http://dx.doi.org/10.1186/s40748-016-0041-x
_version_ 1782496263798784000
author Dall’Asta, Andrea
Brunelli, Valentina
Prefumo, Federico
Frusca, Tiziana
Lees, Christoph C
author_facet Dall’Asta, Andrea
Brunelli, Valentina
Prefumo, Federico
Frusca, Tiziana
Lees, Christoph C
author_sort Dall’Asta, Andrea
collection PubMed
description Fetal growth restriction (FGR) diagnosed before 32 weeks is identified by fetal smallness associated with Doppler abnormalities and is associated with significant perinatal morbidity and mortality and maternal complications. Recent studies have provided new insights into pathophysiology, management options and postnatal outcomes of FGR. In this paper we review the available evidence regarding diagnosis, management and prognosis of fetuses diagnosed with FGR before 32 weeks of gestation.
format Online
Article
Text
id pubmed-5241928
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52419282017-01-23 Early onset fetal growth restriction Dall’Asta, Andrea Brunelli, Valentina Prefumo, Federico Frusca, Tiziana Lees, Christoph C Matern Health Neonatol Perinatol Review Fetal growth restriction (FGR) diagnosed before 32 weeks is identified by fetal smallness associated with Doppler abnormalities and is associated with significant perinatal morbidity and mortality and maternal complications. Recent studies have provided new insights into pathophysiology, management options and postnatal outcomes of FGR. In this paper we review the available evidence regarding diagnosis, management and prognosis of fetuses diagnosed with FGR before 32 weeks of gestation. BioMed Central 2017-01-18 /pmc/articles/PMC5241928/ /pubmed/28116113 http://dx.doi.org/10.1186/s40748-016-0041-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Dall’Asta, Andrea
Brunelli, Valentina
Prefumo, Federico
Frusca, Tiziana
Lees, Christoph C
Early onset fetal growth restriction
title Early onset fetal growth restriction
title_full Early onset fetal growth restriction
title_fullStr Early onset fetal growth restriction
title_full_unstemmed Early onset fetal growth restriction
title_short Early onset fetal growth restriction
title_sort early onset fetal growth restriction
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241928/
https://www.ncbi.nlm.nih.gov/pubmed/28116113
http://dx.doi.org/10.1186/s40748-016-0041-x
work_keys_str_mv AT dallastaandrea earlyonsetfetalgrowthrestriction
AT brunellivalentina earlyonsetfetalgrowthrestriction
AT prefumofederico earlyonsetfetalgrowthrestriction
AT fruscatiziana earlyonsetfetalgrowthrestriction
AT leeschristophc earlyonsetfetalgrowthrestriction

Ejemplares similares